Aravind Nagarajan

ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format

Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital.While the virtual format has undoubtedly impacted attendees’ experiences and

Embracing Agility in Pharma Market Research

The following is based on a presentation given by ZoomRx at the Pharma Market Research Conference in Newark, NJ on Feb 5-6, 2020. Please reach out via the form at the bottom of

Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,

Evaluating Print vs. Digital Aids in Oncology

Equipping reps with digital visual aids is a time and cost-intensive exercise. Consequently, sales leadership teams find themselves grappling with the questions:The conventional logic is that digital aids enable sales reps to

We’ve tracked oncology promotional efforts for 120+ brands across 60,000 interactions over the last 5 years.

Oncology sales forces are complex and nuanced. They carry multiple products and indications, often conveying multiple themes in the same interaction, given the breadth of indications a typical oncologist treats. As a result, an oncology interaction is a prioritization exercise...